Develops thermostable formulation technologies that stabilize vaccines and biologics (viral vectors, mRNA‑LNPs, protein therapeutics) for extended room and elevated‑temperature storage without refrigeration. Enables pharmaceutical and global‑health partners to remove cold‑chain dependency, expanding access in low‑resource and remote settings while cutting logistics costs and environmental impact.